Apple and Samsung reportedly resume patent talks

Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2026

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

Apple and Samsung reportedly resume patent talks

Apple and Samsung have reportedly resumed talks in an effort to settle their differences over patent infringement claims relating to smartphone technology.

The Korea Times reports that the rival companies are trying to work out a deal over royalty payments, while the Korean Fair Trade Commission has teamed up with anti-trust officials in Europe and the US to discuss the situation.

The news is the latest installment in a long-running series of disputes between the two companies over Smartphone technology.

In November, a jury in California revised damages Samsung was required to pay to Apple to just over $900 million. The verdict was the result of a retrial of a jury verdict in August last year, which concluded that Samsung had infringed five utility and design patents relating to the iPhone 5 and awarded Apple $1 billion in damages.

But the Federal Circuit resurrected the chance for Apple to secure a permanent ban on US sales of the infringing products when it unanimously ruled that District Judge Lucy Koh, who presided over the case, erred in denying Apple’s motion for a permanent injunction.

Last week, Apple filed another motion with the same court to block Samsung from selling the products in the US.

In the motion, Apple argues that an injunction would not be against the public interest because Samsung has already stopped selling the products in question, but that without an injunction Samsung could sell other infringing products in future.

Apple has requested a hearing on the motion before January 30.

more from across site and SHARED ros bottom lb

More from across our site

AIPPI has pulled the plug on its planned 2027 World Congress, and INTA has seemingly committed to hosting a meeting there, but the concerns won’t abate
Despite being outspent by a wealthy opponent, a trial attorney at King & Spalding says ‘relentless pursuit of the truth’ helped his team secure a $420m damages award for mobile gaming client
190 drugs face loss of exclusivity between 2026 and 2030, with the list including Bristol Myers Squibb’s blood-thinning drug Eliquis and immunotherapy medication Opdivo
Nokia, represented by a team from Bird & Bird, adjudged to have made fair offer to Asus and Acer in UK SEP dispute
Azhar Sadique and Kane Ridley, who founded the London office in 2023, are now both working in legal tech and AI-related roles, while another UK-based lawyer has also left
Partner Pierre Pérot rejoins the firm he left in 2022 alongside another returning lawyer, associate Camille Abba
Vaping dispute, in which Stobbs and Brandsmiths are the representatives, tested how the UK's Human Rights Act can apply to injunctions restraining unjustified threats
An AI platform being sold for £40m, and lateral hires involving law firms Womble Bond Dickinson and Cadwell Thomas were among the top talking points
With the London Annual Meeting behind us, we look back at some of the lessons learned this week and ahead to what 2027 will bring
In-house counsel aren’t impressed with law firms’ international networks, but practitioners say they are crucial for business
Gift this article